Ghrelin for cachexia
Open Access
- 17 December 2010
- journal article
- research article
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 1 (2), 169-176
- https://doi.org/10.1007/s13539-010-0011-5
Abstract
Ghrelin, a natural ligand for the growth hormone (GH)‐secretagogue receptor, is primarily produced in the stomach. Administration of ghrelin stimulates food intake and GH secretion in both animals and humans. Ghrelin is the only circulating hormone known to stimulate appetite in humans. As GH is an anabolic hormone, protein stores are spared at the expense of fat during conditions of caloric restriction. Ghrelin also inhibits the production of anorectic proinflammatory cytokines. Thus, ghrelin exhibits anti‐cachectic actions via both GH‐dependent and ‐independent mechanisms. Several studies are evaluating the efficacy of ghrelin in the treatment of cachexia caused by a variety of diseases, including congestive heart failure, chronic obstructive pulmonary disease, cancer, and end‐stage renal disease. These studies will hopefully lead to the development of novel clinical applications for ghrelin in the future. These studies have also facilitated a better understanding of the molecular basis of the anti‐catabolic effects of ghrelin. This review summarizes the recent advances in this area of research.This publication has 93 references indexed in Scilit:
- Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and MuscleJournal of Cachexia, Sarcopenia and Muscle, 2010
- Regulation of muscle mass by growth hormone and IGF‐IBritish Journal of Pharmacology, 2008
- Evidence for Acyl-Ghrelin Modulation of Growth Hormone Release in the Fed StateJournal of Clinical Endocrinology & Metabolism, 2008
- Molecular Mechanisms of Ghrelin-Mediated Endothelial Nitric Oxide Synthase ActivationEndocrinology, 2008
- Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathwaysSurgery, 2008
- Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover studyBritish Journal of Cancer, 2008
- Ghrelin Treatment of Chronic Kidney Disease: Improvements in Lean Body Mass and Cytokine ProfileEndocrinology, 2007
- Ghrelin Prevents Cisplatin-Induced Mechanical Hyperalgesia and CachexiaEndocrinology, 2007
- Ghrelin Attenuates Sepsis-induced Acute Lung Injury and Mortality in RatsAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Physiology and immunology of the cholinergic antiinflammatory pathwayJCI Insight, 2007